In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 Mg/Day Is as Effective as Standard Dose of 800 Mg/Day in Patients With Advanced Hepatocellular Carcimona, With Better Tolerance and Similar Survival

Canadian Journal of Gastroenterology
doi 10.1155/2013/170546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Real-World Adverse Events With Niraparib 200 Mg/Day Maintenance Therapy in Ovarian Cancer: A Retrospective Study

Future Oncology
MedicineCancer ResearchOncology
2019English

Low-Dose Hydroxychloroquine Is as Effective as Phlebotomy in Treatment of Patients With Porphyria Cutanea Tarda

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2012English

A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma

Internal Medicine
Internal MedicineMedicine
2013English

Advanced Hepatocellular Carcinoma: Pretreatment Contrast-Enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated With Sorafenib

Radiology
Nuclear MedicineRadiologyImaging
2018English

1-Day Bowel Preparation With Polyethylene Glycol 3350 Is as Effective and Safe as a 3-Day Preparation for Colonoscopy in Children

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies

Clinical Pharmacology and Therapeutics
Pharmacology
2014English

Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With NSTEMI After a 180-Mg Loading Dose

Platelets
MedicineHematology
2017English

Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 Mg; FDC) in Comparison With 400 Mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy